Abstract
Typical side effects of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies including influenza-like illness and injection site reactions, are minor and well tolerated. This case, however, highlights a less common but severe reaction, indicating the need for clinicians to understand and manage potential rare side effects noted with biologics.
Author supplied keywords
Cite
CITATION STYLE
Bimal, T., Szema, A., Pavlovic, M., Karalis, D., & Gianos, E. (2024). Life-Threatening Reaction to Lifesaving Medication: Stepwise Approach to Severe Adverse Reactions to PCSK-9 Monoclonal Antibodies. JACC: Case Reports, 29(19). https://doi.org/10.1016/j.jaccas.2024.102614
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.